MICU2
gene geneOn this page
Summary
MICU2 (mitochondrial calcium uptake 2, HGNC:31830) is a protein-coding gene on chromosome 13q12.11, encoding Calcium uptake protein 2, mitochondrial (Q8IYU8). Calcium sensor of the mitochondrial calcium uniporter (MCU) channel, which senses calcium level via its EF-hand domains.
Enables several functions, including calcium channel regulator activity; calcium ion sensor activity; and protein heterodimerization activity. Involved in calcium import into the mitochondrion; cellular response to calcium ion; and negative regulation of mitochondrial calcium ion concentration. Located in mitochondrial intermembrane space. Part of uniplex complex. Is active in mitochondrial inner membrane.
Source: NCBI Gene 221154 — RefSeq curated summary.
At a glance
- Gene–disease (curated): mitochondrial disease (Limited, ClinGen)
- GWAS associations: 21
- Clinical variants (ClinVar): 78 total
- MANE Select transcript:
NM_152726
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31830 |
| Approved symbol | MICU2 |
| Name | mitochondrial calcium uptake 2 |
| Location | 13q12.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000165487 |
| Ensembl biotype | protein_coding |
| OMIM | 610632 |
| Entrez | 221154 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 10 protein_coding, 6 protein_coding_CDS_not_defined
ENST00000382374, ENST00000460488, ENST00000468222, ENST00000469058, ENST00000476895, ENST00000478700, ENST00000479790, ENST00000480341, ENST00000903401, ENST00000903402, ENST00000903403, ENST00000903404, ENST00000903405, ENST00000903406, ENST00000937097, ENST00000954298
RefSeq mRNA: 1 — MANE Select: NM_152726
NM_152726
CCDS: CCDS9297
Canonical transcript exons
ENST00000382374 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001093547 | 21502926 | 21503097 |
| ENSE00001260786 | 21496052 | 21496160 |
| ENSE00001835008 | 21492691 | 21493353 |
| ENSE00001873874 | 21603939 | 21604170 |
| ENSE00003478066 | 21514353 | 21514418 |
| ENSE00003516814 | 21521245 | 21521327 |
| ENSE00003525560 | 21539657 | 21539688 |
| ENSE00003548202 | 21566797 | 21566944 |
| ENSE00003582781 | 21522603 | 21522650 |
| ENSE00003631284 | 21539302 | 21539377 |
| ENSE00003635266 | 21495161 | 21495318 |
| ENSE00003653044 | 21510004 | 21510101 |
Expression profiles
Bgee: expression breadth ubiquitous, 292 present calls, max score 98.00.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 42.4595 / max 270.0191, expressed in 1821 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 136391 | 42.4595 | 1821 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| choroid plexus epithelium | UBERON:0003911 | 98.00 | gold quality |
| heart right ventricle | UBERON:0002080 | 97.57 | gold quality |
| renal medulla | UBERON:0000362 | 97.18 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 96.94 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.86 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.81 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.74 | gold quality |
| nephron tubule | UBERON:0001231 | 96.52 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 96.14 | gold quality |
| myocardium | UBERON:0002349 | 96.14 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.01 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 95.97 | gold quality |
| biceps brachii | UBERON:0001507 | 95.95 | gold quality |
| superior surface of tongue | UBERON:0007371 | 95.77 | gold quality |
| jejunum | UBERON:0002115 | 95.68 | gold quality |
| cerebellum | UBERON:0002037 | 95.66 | gold quality |
| colonic mucosa | UBERON:0000317 | 95.65 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 95.63 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.62 | gold quality |
| oral cavity | UBERON:0000167 | 95.57 | gold quality |
| jejunal mucosa | UBERON:0000399 | 95.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.55 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 95.55 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 95.37 | gold quality |
| adrenal tissue | UBERON:0018303 | 95.32 | gold quality |
| body of tongue | UBERON:0011876 | 95.30 | gold quality |
| metanephros | UBERON:0000081 | 95.24 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.18 | gold quality |
| skin of hip | UBERON:0001554 | 95.17 | gold quality |
| kidney epithelium | UBERON:0004819 | 95.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.99 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): YY1
miRNA regulators (miRDB)
30 targeting MICU2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-6848-3P | 99.64 | 66.49 | 885 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-888-3P | 99.53 | 69.77 | 1057 |
| HSA-MIR-4666A-5P | 99.41 | 69.72 | 1887 |
| HSA-MIR-377-3P | 99.37 | 70.18 | 1905 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-148A-5P | 99.30 | 68.27 | 1141 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
| HSA-MIR-6843-3P | 99.26 | 66.42 | 915 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-5590-5P | 98.81 | 68.78 | 969 |
| HSA-MIR-3149 | 98.77 | 67.13 | 1639 |
| HSA-MIR-5094 | 98.63 | 67.11 | 1062 |
| HSA-MIR-8060 | 98.61 | 66.93 | 1187 |
| HSA-MIR-15B-3P | 97.85 | 66.68 | 974 |
| HSA-MIR-1231 | 95.10 | 65.63 | 663 |
Literature-anchored findings (GeneRIF, showing 13)
- The results identify MICU2 as a new component of the uniporter complex that may contribute to the tissue-specific regulation of this channel. (PMID:23409044)
- regulation of MCU-mediated mitochondrial calcium handling (PMID:23409044)
- Expression of MICU2 mutants lacking functional Ca2+-binding sites leads to a striking loss of Ca2+ uptake in HEK293 cells. (PMID:24503055)
- MICU1 and MICU2 have roles in tuning the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity (PMID:24560927)
- study concludes that cooperative, high-affinity interaction of the MICU1-MICU2 complex with Ca(2+) serves as an on-off switch, leading to a tightly controlled channel, capable of responding directly to cytosolic Ca(2+) signals (PMID:28615291)
- This is the first demonstration of MICU2 deficiency in humans, which we suggest causes a distinct neurodevelopmental phenotype secondary to impaired mitochondrial calcium uniporter-mediated regulation of intracellular calcium homeostasis. (PMID:29053821)
- MICU2 expression in the heart tissues from patients with ventricular hypertrophy. (PMID:29073106)
- MICU2 restricts spatial crosstalk between InsP3R and MCU channels by regulating threshold and gain of MICU1-mediated inhibition and activation of MCU. (PMID:29241542)
- multiple crystal structures of MICU2 and MICU3 from Homo sapiens, were determined. (PMID:30699349)
- Structures reveal gatekeeping of the mitochondrial Ca(2+) uniporter by MICU1-MICU2. (PMID:32667285)
- The structure of the MICU1-MICU2 complex unveils the regulation of the mitochondrial calcium uniporter. (PMID:32790952)
- Mechanisms of EMRE-Dependent MCU Opening in the Mitochondrial Calcium Uniporter Complex. (PMID:33296646)
- Mitochondrial clearance of calcium facilitated by MICU2 controls insulin secretion. (PMID:33932586)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | micu2 | ENSDARG00000009939 |
| mus_musculus | Micu2 | ENSMUSG00000021973 |
| rattus_norvegicus | Micu2 | ENSRNOG00000011168 |
| caenorhabditis_elegans | WBGENE00008345 |
Paralogs (2): MICU1 (ENSG00000107745), MICU3 (ENSG00000155970)
Protein
Protein identifiers
Calcium uptake protein 2, mitochondrial — Q8IYU8 (reviewed: Q8IYU8)
Alternative names: EF-hand domain-containing family member A1
All UniProt accessions (3): A0A0A0MTD5, A0A0S2Z6V5, Q8IYU8
UniProt curated annotations — full annotation on UniProt →
Function. Calcium sensor of the mitochondrial calcium uniporter (MCU) channel, which senses calcium level via its EF-hand domains. MICU1 and MICU2 form a disulfide-linked heterodimer that stimulates and inhibits MCU activity, depending on the concentration of calcium. At low calcium levels, MICU1 occludes the pore of the MCU channel, preventing mitochondrial calcium uptake. At higher calcium levels, calcium-binding to MICU1 and MICU2 induces a conformational change that weakens MCU-MICU1 interactions and moves the MICU1-MICU2 heterodimer away from the pore, allowing calcium permeation through the MCU channel.
Subunit / interactions. Heterodimer; disulfide-linked; heterodimerizes with MICU1. Component of the uniplex complex, composed of MCU, EMRE/SMDT1, MICU1 and MICU2 in a 4:4:1:1 stoichiometry.
Subcellular location. Mitochondrion intermembrane space. Mitochondrion inner membrane.
Domain organisation. EF-hand domains 1 and 4 have high affinity for calcium and act as sensors of mitochondrial matrix calcium levels. EF-hand domains 2 and 3 are degenerate.
Similarity. Belongs to the MICU1 family. MICU2 subfamily.
RefSeq proteins (1): NP_689939* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR039800 | MICU1/2/3 | Family |
UniProt features (64 total): helix 19, mutagenesis site 13, binding site 11, strand 7, domain 4, turn 4, transit peptide 1, chain 1, modified residue 1, disulfide bond 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
12 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6IIH | X-RAY DIFFRACTION | 1.96 |
| 6LB7 | X-RAY DIFFRACTION | 2.1 |
| 6AGH | X-RAY DIFFRACTION | 2.74 |
| 6LE5 | X-RAY DIFFRACTION | 3.1 |
| 6XQO | ELECTRON MICROSCOPY | 3.1 |
| 6WDN | ELECTRON MICROSCOPY | 3.2 |
| 6LB8 | X-RAY DIFFRACTION | 3.28 |
| 6XQN | ELECTRON MICROSCOPY | 3.3 |
| 6K7Y | ELECTRON MICROSCOPY | 3.6 |
| 6WDO | ELECTRON MICROSCOPY | 3.6 |
| 6XJV | ELECTRON MICROSCOPY | 4.17 |
| 6XJX | ELECTRON MICROSCOPY | 4.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYU8-F1 | 75.75 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (11): 193; 196; 375; 377; 379; 381; 386; 185; 187; 189; 191
Post-translational modifications (1): 205
Disulfide bonds (1): 413
Mutagenesis-validated functional residues (13):
| Position | Phenotype |
|---|---|
| 107 | does not affect its ability to regulate the activity of mcu; when associated with 120-e-e-121 and r-154. |
| 120–121 | does not affect its ability to regulate the activity of mcu; when associated with e-107 and r-154. |
| 154 | does not affect its ability to regulate the activity of mcu; when associated with e-107 and 120-e-e-121. |
| 172 | does not affect interaction with micu1. |
| 185 | abolishes mitochondrial ca(2+) uptake; when associated with a-375 and a-386. in ef1(mut); decreased calcium-binding and |
| 196 | in ef1(mut); decreased calcium-binding and abolished ability to interact with micu1 when associated with a-185. |
| 206 | does not affect interaction with micu2. |
| 329 | does not affect interaction with micu1. |
| 336 | decreased interaction with micu1. |
| 352 | abolished interaction with micu1. |
| 352 | abilished interaction with micu1 and ability to regulate the activity of mcu. |
| 375 | abolishes mitochondrial ca(2+) uptake; when associated with a-185 and a-386. |
| 386 | abolishes mitochondrial ca(2+) uptake; when associated with a-185 and a-375. |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-8949215 | Mitochondrial calcium ion transport |
| R-HSA-8949664 | Processing of SMDT1 |
| R-HSA-9837999 | Mitochondrial protein degradation |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-392499 | Metabolism of proteins |
MSigDB gene sets: 134 (showing top):
GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_RESPONSE_TO_METAL_ION, GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOCC_MITOCHONDRIAL_ENVELOPE, SCHLOSSER_SERUM_RESPONSE_DN, GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION, GOBP_MONOATOMIC_ION_HOMEOSTASIS, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, ACEVEDO_LIVER_CANCER_UP, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_RESPONSE_TO_CALCIUM_ION, TGGAAA_NFAT_Q4_01, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (6): mitochondrial calcium ion transmembrane transport (GO:0006851), calcium import into the mitochondrion (GO:0036444), mitochondrial calcium ion homeostasis (GO:0051560), positive regulation of mitochondrial calcium ion concentration (GO:0051561), negative regulation of mitochondrial calcium ion concentration (GO:0051562), cellular response to calcium ion (GO:0071277)
GO Molecular Function (5): calcium channel regulator activity (GO:0005246), calcium ion binding (GO:0005509), protein heterodimerization activity (GO:0046982), calcium ion sensor activity (GO:0061891), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial intermembrane space (GO:0005758), calcium channel complex (GO:0034704), uniplex complex (GO:1990246), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Transport of small molecules | 1 |
| Mitochondrial calcium ion transport | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrial calcium ion homeostasis | 2 |
| calcium ion transmembrane transport | 1 |
| mitochondrial calcium ion transmembrane transport | 1 |
| intercellular transport | 1 |
| mitochondrion | 1 |
| intracellular calcium ion homeostasis | 1 |
| response to calcium ion | 1 |
| cellular response to metal ion | 1 |
| calcium channel activity | 1 |
| ion channel regulator activity | 1 |
| metal ion binding | 1 |
| protein dimerization activity | 1 |
| calcium ion binding | 1 |
| metal ion sensor activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrial envelope | 1 |
| organelle envelope lumen | 1 |
| cation channel complex | 1 |
| calcium channel complex | 1 |
| inner mitochondrial membrane protein complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
884 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MICU2 | SMDT1 | Q9H4I9 | 999 |
| MICU2 | MCUR1 | Q96AQ8 | 998 |
| MICU2 | MCUB | Q9NWR8 | 998 |
| MICU2 | MCU | Q8NE86 | 995 |
| MICU2 | MICU1 | Q9BPX6 | 988 |
| MICU2 | MICU3 | Q86XE3 | 973 |
| MICU2 | SLC25A23 | Q9BV35 | 911 |
| MICU2 | VDAC1 | P21796 | 776 |
| MICU2 | SLC8B1 | Q6J4K2 | 775 |
| MICU2 | FGF20 | Q9NP95 | 767 |
| MICU2 | LETM1 | O95202 | 764 |
| MICU2 | FGF9 | P31371 | 762 |
| MICU2 | ITPR3 | Q14573 | 729 |
| MICU2 | ITPR1 | Q14643 | 719 |
| MICU2 | CHCHD4 | Q8N4Q1 | 653 |
IntAct
95 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MICU2 | MICU1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MICU1 | MICU2 | psi-mi:“MI:0914”(association) | 0.780 |
| MICU1 | MICU2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| RANBP6 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.640 |
| CHCHD4 | SSNA1 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL22 | METTL15 | psi-mi:“MI:0914”(association) | 0.640 |
| BPNT1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM44 | ODAD3 | psi-mi:“MI:0914”(association) | 0.530 |
| SPACA1 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| DCAF11 | GNPAT | psi-mi:“MI:0914”(association) | 0.530 |
| ATG7 | GFER | psi-mi:“MI:0914”(association) | 0.530 |
| MCU | MICU2 | psi-mi:“MI:0914”(association) | 0.530 |
| CXCR4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| ARMC6 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.530 |
| PON1 | PON3 | psi-mi:“MI:0914”(association) | 0.530 |
| PYCR3 | RPL23 | psi-mi:“MI:0914”(association) | 0.530 |
| SMDT1 | MICU2 | psi-mi:“MI:0915”(physical association) | 0.490 |
| HTRA2 | HAX1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| JUN | TPM3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (137): MICU2 (Affinity Capture-MS), ASH2L (Affinity Capture-MS), MICU1 (Affinity Capture-MS), ACOX3 (Affinity Capture-MS), CSNK1E (Affinity Capture-MS), CSNK1D (Affinity Capture-MS), GAPVD1 (Affinity Capture-MS), SMAP1 (Affinity Capture-MS), KIAA1217 (Affinity Capture-MS), MICU2 (Affinity Capture-MS), MICU1 (Affinity Capture-MS), ACOX3 (Affinity Capture-MS), KLHL22 (Affinity Capture-MS), SMAP1 (Affinity Capture-MS), MICU2 (Affinity Capture-MS)
ESM2 similar proteins: A0A060LAL9, A0A097ZPE6, A0A1I9R3Y5, A2VEI2, A2XVG1, A8B479, A8WQT4, B3H7A9, F4I1L3, G1JSL4, H2E7T7, O22585, O22788, O45228, O64407, O65015, O81270, P10538, P16098, Q0KHU5, Q19337, Q28C60, Q2QRX6, Q43727, Q5QIT3, Q5R8Y6, Q5Z8Y4, Q66HG5, Q6DCK1, Q7FAX1, Q7JW12, Q8CD10, Q8IYU8, Q8VZQ4, Q95PZ2, Q99805, Q99P63, Q9CAB7, Q9CAB8, Q9D5U0
Diamond homologs: A0A8I6A2H6, Q86XE3, Q8CD10, Q8IYU8, Q99P63, Q9CTY5, A2VEI2, A4IG32, A8WQT4, B1H2N3, D2HZB0, Q0IIL1, Q4R518, Q6P6Q9, Q8VCX5, Q95PZ2, Q9BPX6, Q9SZ45, F1LX07
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MICU2 | “form complex” | MCU_MICUB_variant | binding |
| MICU2 | “form complex” | MCU_MICU2_variant | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 119 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Processing of SMDT1 | 5 | 46.0× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
78 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2437 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:21493350:GTACC:G | acceptor_loss | 1.0000 |
| 13:21493352:ACCT:A | acceptor_loss | 1.0000 |
| 13:21493353:CCTG:C | acceptor_loss | 1.0000 |
| 13:21493362:C:CT | acceptor_gain | 1.0000 |
| 13:21493362:C:T | acceptor_gain | 1.0000 |
| 13:21495314:CTCCG:C | acceptor_gain | 1.0000 |
| 13:21495315:TCCG:T | acceptor_gain | 1.0000 |
| 13:21495316:CCG:C | acceptor_gain | 1.0000 |
| 13:21495316:CCGC:C | acceptor_gain | 1.0000 |
| 13:21495317:CG:C | acceptor_gain | 1.0000 |
| 13:21495317:CGC:C | acceptor_gain | 1.0000 |
| 13:21495319:C:CC | acceptor_gain | 1.0000 |
| 13:21496159:CT:C | acceptor_gain | 1.0000 |
| 13:21496161:C:CC | acceptor_gain | 1.0000 |
| 13:21510000:TTAC:T | donor_loss | 1.0000 |
| 13:21510001:TAC:T | donor_loss | 1.0000 |
| 13:21510002:A:C | donor_loss | 1.0000 |
| 13:21510098:CTTC:C | acceptor_gain | 1.0000 |
| 13:21510100:TCC:T | acceptor_loss | 1.0000 |
| 13:21510102:C:CC | acceptor_gain | 1.0000 |
| 13:21510103:T:A | acceptor_loss | 1.0000 |
| 13:21514348:CATA:C | donor_loss | 1.0000 |
| 13:21514349:ATAC:A | donor_loss | 1.0000 |
| 13:21514350:TA:T | donor_loss | 1.0000 |
| 13:21514351:A:AG | donor_loss | 1.0000 |
| 13:21514352:C:A | donor_loss | 1.0000 |
| 13:21521238:CACTT:C | donor_loss | 1.0000 |
| 13:21521239:ACTTA:A | donor_loss | 1.0000 |
| 13:21521240:CTTAC:C | donor_loss | 1.0000 |
| 13:21521241:TTACC:T | donor_loss | 1.0000 |
AlphaMissense
2885 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:21502999:A:G | L287P | 0.998 |
| 13:21495312:A:G | F350S | 0.997 |
| 13:21566829:A:G | F109S | 0.997 |
| 13:21495248:A:C | F371L | 0.996 |
| 13:21495248:A:T | F371L | 0.996 |
| 13:21495250:A:G | F371L | 0.996 |
| 13:21503055:G:C | F268L | 0.996 |
| 13:21503055:G:T | F268L | 0.996 |
| 13:21503057:A:G | F268L | 0.996 |
| 13:21495216:A:G | L382P | 0.995 |
| 13:21495216:A:T | L382H | 0.995 |
| 13:21495239:A:C | F374L | 0.995 |
| 13:21495239:A:T | F374L | 0.995 |
| 13:21495241:A:G | F374L | 0.995 |
| 13:21495252:A:T | V370D | 0.995 |
| 13:21503011:A:G | F283S | 0.995 |
| 13:21503056:A:G | F268S | 0.995 |
| 13:21495201:A:G | F387S | 0.994 |
| 13:21496060:A:T | V345D | 0.994 |
| 13:21496141:A:G | F318S | 0.994 |
| 13:21503003:A:G | W286R | 0.994 |
| 13:21503003:A:T | W286R | 0.994 |
| 13:21521299:A:C | F181L | 0.994 |
| 13:21521299:A:T | F181L | 0.994 |
| 13:21521301:A:G | F181L | 0.994 |
| 13:21522617:A:G | L167P | 0.994 |
| 13:21566876:A:C | F93L | 0.994 |
| 13:21566876:A:T | F93L | 0.994 |
| 13:21566878:A:G | F93L | 0.994 |
| 13:21566885:G:C | F90L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000007474 (13:21493412 T>C,G), RS1000110671 (13:21576462 T>C), RS1000190205 (13:21538009 T>C), RS1000201238 (13:21546132 A>T), RS1000216648 (13:21529465 G>C), RS1000258202 (13:21525172 T>C), RS1000289251 (13:21499416 C>T), RS1000394077 (13:21517989 A>G), RS1000394234 (13:21588040 G>C), RS1000401321 (13:21501191 T>C), RS1000405153 (13:21603685 G>A,T), RS1000430748 (13:21562931 T>A,C), RS1000451708 (13:21598229 T>C), RS1000452272 (13:21501348 T>C), RS1000472243 (13:21588254 T>G)
Disease associations
OMIM: gene MIM:610632 | disease phenotypes:
GenCC curated gene-disease
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial disease | Limited | AR |
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002456_7 | PR segment duration | 3.000000e-10 |
| GCST007045_37 | PR interval | 3.000000e-24 |
| GCST007226_3 | PR interval | 7.000000e-12 |
| GCST009391_1799 | Metabolite levels | 6.000000e-08 |
| GCST009391_1882 | Metabolite levels | 3.000000e-06 |
| GCST009391_1891 | Metabolite levels | 2.000000e-06 |
| GCST010321_145 | PR interval | 1.000000e-51 |
| GCST010796_3876 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_3877 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-10 |
| GCST010796_3878 | Electrocardiogram morphology (amplitude at temporal datapoints) | 7.000000e-09 |
| GCST010796_3879 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
| GCST010796_3917 | Electrocardiogram morphology (amplitude at temporal datapoints) | 9.000000e-13 |
| GCST010796_3918 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-12 |
| GCST010796_3919 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_3920 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-11 |
| GCST010796_3921 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-12 |
| GCST010796_3922 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_3923 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-11 |
| GCST010796_3924 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-11 |
| GCST010796_3925 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-12 |
| GCST011010_21 | Electrocardiographic traits (multivariate) | 4.000000e-09 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005095 | PR segment |
| EFO:0004462 | PR interval |
| EFO:0010529 | ribose-5-phosphate measurement |
| EFO:0010530 | ribulose-5-phosphate measurement |
| EFO:0010414 | triacylglycerol 52:2 measurement |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: other ic — Mitochondrial calcium uniporter (MCU) complex
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylselenic acid | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| MT19c compound | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Urethane | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D8QL | Ubigene HCT 116 MICU2 KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: mitochondrial disease